Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent <i>Clostridioides difficile</i> Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS
20255 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 7.58
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent <i>Clostridioides difficile</i> Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS | Researchclopedia